Home
 
   

 

NEWS:                    


April 2010
SIRION BIOTECH entered into a license agreement with TET Systems granting rights for a inducible and reversible expression of proteins or siRNA. In the laboratories of SIRION BIOTECH this new technical option will be used for creating inducible cell and vector systems for the project business.

January 21, 2010
SIRION BIOTECH and Sigma-Aldrich entered into a service agreement under which SIRION BIOTECH provides custom shRNA knockdown cell lines, utilizing validated The RNAi Consortium (TRC) shRNA RNAi libraries from Sigma Life Science. First of all the offer is limited to the German research community.

January 2010
SIRION BIOTECH successfully completes a test phase with more than 80 test sites for its new product TransMAX, an enhancer of adenovirus uptake, and launches TransMAX   >>


 
 

 

Your expert for genetically modified cells


Q-tech

Your fastest track to RNAi results

Learn about Q-tech – here
Find your RNAi target in our Q-tech select program – here

 

Adenovirus Technology

The gateway to your cells

Gene delivery by Adenoviruses – here
SIRION BIOTECH's adenovirus services – here

 

Stable RNAi

Long term silencing

MISSION shRNA cells – here
Inducible system for in vivo target validation – here

 

With our solid and long-lasting expertise in design and use of viral vector systems for genetical engineering of mammalian cells we offer a reliable lead-through of your projects in target validation, gene delivery and library cloning.

 
 

Press Releases

View the archive of SIRION BIOTECH press releases
> View Press Releases

 

Sales Contact

For prices and further information please inquire:

T. +49 89 700 96 19 99
info@sirion-biotech.de

 

Refer this page to a colleague or friend.

  click here

 

Test our Adenovirus Transduction Reagent
TransMAX

More about TransMAX

Order TransMAX here directly

 

SIRION BITOECH is
industry partner of